PellePharm, Inc.

PellePharm, Inc.

PellePharm, Inc.

Overview
Date Founded

2012

Headquarters

101 Mission Street,Suite 2050,San Francisco, CA 94105

Type of Company

Private

Industries

Biotechnology
Holding Companies
Pharmaceuticals

Company Description

PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. It also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA.

Executives & Employees

Co-Founder & Director

Co-Founder

President, Chief Executive Officer & Director

Vice President of Regulatory Affairs

Vice President of Technical Operations & Program Management

Board of Directors

President, Chief Executive Officer & Director at PellePharm, Inc.

Co-Founder at Bridgebio Pharma LLC

Professor, Department of Cellular & Molecular Pharmacology at UCSF School of Medicine

Co-Founder & Director at PellePharm, Inc.

Co-Founder at PellePharm, Inc.

Member, Board of Directors at PellePharm, Inc.

Paths to PellePharm, Inc.
Potential Connections via
Relationship Science
You
PellePharm, Inc.
Recent Transactions
Details Hidden

PellePharm, Inc. raised money in a private placement transaction

Details Hidden

PellePharm, Inc. raised money in a private placement transaction

Details Hidden

PellePharm, Inc. raised money in a private placement transaction

Investors
Details Hidden

Aisling Capital LLC invests in private and small cap publicly traded equities located in the US. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies. It provides equity, debt and other structured securities financing for royalty deals, large cap leveraged buyout, seed and venture financing of development stage companies.

Details Hidden

BridgeBio Pharma LLC discovers and develops pharmaceutical drugs for patients with genetic diseases. The firm offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA.

Details Hidden

Co-Founder & Director at PellePharm, Inc.

Suppliers
Infinity Pharmaceuticals, Inc. Pharmaceuticals | Cambridge, Massachusetts

Infinity is an innovative drug discovery and development company dedicated to discovering, developing and delivering to patients best-in-class medicines for diseases with significant unmet need. We believe that our small molecule discovery and development capabilities, strategic alliances, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by PellePharm, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of PellePharm, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and PellePharm, Inc..